CURRENT POSSIBILITIES OF GLYCEMIC SELF-CONTROL IN THE TREATMENT OF DIABETES MELLITUS. LECTURE

Diabetes mellitus (DM) is an urgent problem of modern medicine. This disease is associated with vascular events that determine the prognosis of patients' lives (nephropathy, retinopathy, damage to great vessels of the heart, brain, arteries of the lower extremities). Achieving glycemic control plays a key role in preventing these complications. Current clinical guidelines on patient treatment which offer an approach of an individualized choice of therapy goals by glycated hemoglobin (HbA1c) based on the patient's age, life expectancy, presence of atherosclerotic cardiovascular disease and the risk of severe hypoglycemia are discussed. To determine the individual level of HbA1c in elderly patients, these principles imply a simple division into functionally independent and functionally dependent individuals. The role of self-control of glycaemia is emphasized as the basis for the effectiveness of ongoing hypoglycemic therapy and the prevention of hypoglycemia, the frequency of self-control is discussed. The key role of glycemic self-control for the efficacy of glucose-lowering therapy and prevention of hypoglycemia is emphasized and the frequency of self-control is discussed. Important criteria for choosing a glucometer are compliance with accuracy standards, simplicity and ease of use, ease of obtaining results, which allows patients of any age to take measurements of blood glucose levels. With the development of technology, new “smart” glucometers have appeared, which, thanks to integration with a free mobile application (available on the Internet), enable remote monitoring and significantly expand the capabilities of managing diabetes.

diabetes mellitus, complications, clinical guidelines, glycemic self-control, glycated hemoglobin, glucometers